The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.27
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 14.27
CLLN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

8 May 2014 10:43

RNS Number : 5921G
Carillion PLC
08 May 2014
 

Carillion plc

(the Company)

 

Annual General Meeting (AGM) 7 May 2014

 

It is confirmed that all of the resolutions put to the Company's shareholders at the AGM held yesterday were duly passed on a show of hands.

 

 

Tim George

Deputy Company Secretary

8 May 2014

 

Proxy Voting Figures

Resolution Number

Resolution

Number of

Votes For

Number of Votes Against

Number of Votes Discretionary

Total Votes Cast (excluding Withheld)

Number of Votes Withheld

 

Total % of Issued Share Capital Voted (Including Withheld)

01

To receive the 2013 Accounts

254,780,684

235,703

352,992

255,369,379

964,615

59.58%

02

To approve the remuneration report

233,244,915

10,353,158

329,624

243,927,697

12,406,297

59.58%

03

To approve the Directors' Remuneration Policy

227,921,273

9,197,020

322,064

237,440,357

18,893,637

59.58%

04

To declare a final dividend of 12.0p

255,042,874

15,258

327,608

255,385,740

948,254

59.58%

05

To elect Alison Horner

251,305,222

318,061

341,978

251,965,261

4,368,733

59.58%

06

To elect Ceri Powell

254,664,943

312,165

335,456

255,312,564

1,021,430

59.58%

07

To re-elect Richard Adam

254,393,974

600,379

335,816

255,330,169

1,003,825

59.58%

08

To re-elect Andrew Dougal

254,699,192

295,480

332,481

255,327,153

1,006,841

59.58%

09

To re-elect Philip Green

254,389,349

606,969

330,531

255,326,849

1,007,145

59.58%

10

To re-elect Richard Howson

232,328,004

22,670,949

331,382

255,330,335

1,003,659

59.58%

11

To re-elect Steve Mogford

247,503,572

2,844,324

338,105

250,686,001

5,647,993

59.58%

12

To appoint KPMG LLP

248,053,521

5,421,327

330,128

253,804,976

2,529,018

59.58%

13

To determine the auditor's remuneration

253,329,348

152,355

327,875

253,809,578

2,524,416

59.58%

14

Diectors to allot shares

238,699,757

16,281,643

329,722

255,311,122

1,021,872

59.58%

15

To approve the rules of the 2014 LTIP

242,294,645

12,622,495

341,692

255,258,832

1,075,162

59.58%

16*

To disapply pre-emption rights

230,160,359

24,785,111

339,582

255,285,052

1,048,942

59.58%

17*

To purchase own shares

254,837,913

157,890

335,198

255,331,001

1,002,993

59.58%

18*

To allow a general meeting on 14 days' notice

219,561,709

35,456,182

343,440

255,361,331

972,662

59.58%

*Special resolutions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMGCGDUCXGBGSI
Date   Source Headline
3rd Apr 20187:30 amRNSUpdate re Liquidation of Carillion
19th Mar 20187:00 amRNSFRC investigation
17th Jan 20188:15 amRNSAnnouncement Re. Carillion PLC
15th Jan 20187:45 amRNSSuspension - Carillion PLC
15th Jan 20187:00 amRNSCompulsory liquidation of Carillion
12th Jan 20186:08 pmRNSUpdate on discussions with creditors
12th Jan 20185:08 pmRNSHolding(s) in Company
10th Jan 20185:48 pmRNSHolding(s) in Company
9th Jan 20187:03 amRNSResponse to share price movement
3rd Jan 20184:44 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSRegulatory investigation
22nd Dec 20177:00 amRNSUpdate on financial covenant deferral
20th Dec 201710:16 amRNSBlock listing Interim Review
20th Dec 20177:00 amRNSChief Executive Appointment
13th Dec 20177:00 amRNSUpdate on UK healthcare facilities business
11th Dec 20177:58 amRNSHolding(s) in Company
1st Dec 20177:00 amRNSDirectorate Change
23rd Nov 201712:08 pmRNSHolding(s) in Company
22nd Nov 201712:29 pmRNSHolding(s) in Company
21st Nov 20174:11 pmRNSHolding(s) in Company
20th Nov 20177:00 amRNSFramework Award
17th Nov 20177:02 amRNSUpdate
15th Nov 20177:00 amRNSOman - letter of award for contract
6th Nov 20177:00 amRNSContract wins
2nd Nov 20177:00 amRNSDirectorate Change
31st Oct 20177:00 amRNSDisposal
27th Oct 20177:00 amRNSChief Executive Appointment
24th Oct 20177:00 amRNSUpdate on financing, disposals and work winning
12th Oct 201712:43 pmRNSUK Healthcare business
4th Oct 20172:58 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSHalf-year Report
22nd Sep 20171:00 pmRNSHolding(s) in Company
19th Sep 20174:55 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:17 pmRNSAnnouncement of 2017 interim results
17th Aug 20174:19 pmRNSHolding(s) in Company
15th Aug 20175:58 pmRNSHolding(s) in Company
11th Aug 20176:20 pmRNSHolding(s) in Company
8th Aug 20173:59 pmRNSHolding(s) in Company
8th Aug 201710:02 amRNSHolding(s) in Company
3rd Aug 20179:02 amRNSHolding(s) in Company
1st Aug 201712:24 pmRNSHolding(s) in Company
31st Jul 20172:57 pmRNSHolding(s) in Company
27th Jul 20176:28 pmRNSHolding(s) in Company
18th Jul 201710:49 amRNSHolding(s) in Company
18th Jul 20177:00 amRNSCarillion JV awarded two further HESTIA contracts
17th Jul 20177:19 amRNSHS2 Contract Award
17th Jul 20177:00 amRNSCarillion appoints EY to support strategic review
14th Jul 201712:20 pmRNSHolding(s) in Company
14th Jul 20177:00 amRNSAppointment of Joint Financial Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.